Ginsenosides in hepatocellular carcinoma: preclinical evidence, mechanisms, and clinical implications.

Journal: Frontiers in Pharmacology •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Yu C, Zhu X, Liu S, et al. (2026). "Ginsenosides in hepatocellular carcinoma: preclinical evidence, mechanisms, and clinical implications.". Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1973780